Abnormal accumulation of autophagic vesicles correlates with axonal and synaptic pathology in young Alzheimer’s mice hippocampus

Dystrophic neurites associated with amyloid plaques precede neuronal death and manifest early in Alzheimer’s disease (AD). In this work we have characterized the plaque-associated neuritic pathology in the hippocampus of young (4- to 6-month-old) PS1M146L/APP751SL mice model, as the initial degenerative process underlying functional disturbance prior to neuronal loss. Neuritic plaques accounted for almost all fibrillar deposits and an axonal origin of the dystrophies was demonstrated. The early induction of autophagy pathology was evidenced by increased protein levels of the autophagosome marker LC3 that was localized in the axonal dystrophies, and by electron microscopic identification of numerous autophagic vesicles filling and causing the axonal swellings. Early neuritic cytoskeletal defects determined by the presence of phosphorylated tau (AT8-positive) and actin–cofilin rods along with decreased levels of kinesin-1 and dynein motor proteins could be responsible for this extensive vesicle accumulation within dystrophic neurites. Although microsomal Aβ oligomers were identified, the presence of A11-immunopositive Aβ plaques also suggested a direct role of plaque-associated Aβ oligomers in defective axonal transport and disease progression. Most importantly, presynaptic terminals morphologically disrupted by abnormal autophagic vesicle buildup were identified ultrastructurally and further supported by synaptosome isolation. Finally, these early abnormalities in axonal and presynaptic structures might represent the morphological substrate of hippocampal dysfunction preceding synaptic and neuronal loss and could significantly contribute to AD pathology in the preclinical stages.

[1]  S. Tooze,et al.  Microtubules Facilitate Autophagosome Formation and Fusion of Autophagosomes with Endosomes , 2006, Traffic.

[2]  D. Salmon,et al.  Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment , 1991, Annals of neurology.

[3]  D. Selkoe,et al.  Soluble amyloid β-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration , 2011, Proceedings of the National Academy of Sciences.

[4]  Ralph A. Nixon,et al.  Extensive Involvement of Autophagy in Alzheimer Disease: An Immuno-Electron Microscopy Study , 2005, Journal of neuropathology and experimental neurology.

[5]  Kristina D. Micheva,et al.  Oligomeric amyloid β associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques , 2009, Proceedings of the National Academy of Sciences.

[6]  C. Almeida,et al.  Intraneuronal Abeta accumulation and origin of plaques in Alzheimer's disease. , 2005, Neurobiology of aging.

[7]  S. DeKosky,et al.  Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity , 1990, Annals of neurology.

[8]  David M Holtzman,et al.  Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo. , 2005, Neuron.

[9]  D. Holtzman,et al.  Rapid Microglial Response Around Amyloid Pathology after Systemic Anti-Aβ Antibody Administration in PDAPP Mice , 2008, The Journal of Neuroscience.

[10]  Thomas Arendt,et al.  Synaptic degeneration in Alzheimer’s disease , 2009, Acta Neuropathologica.

[11]  G. Bloom,et al.  Cytoskeletal pathologies of Alzheimer disease. , 2009, Cell motility and the cytoskeleton.

[12]  P. Adlard,et al.  Dystrophic neurites in TgCRND8 and Tg2576 mice mimic human pathological brain aging , 2009, Neurobiology of Aging.

[13]  D. Westaway,et al.  Lysosomal Proteolysis and Autophagy Require Presenilin 1 and Are Disrupted by Alzheimer-Related PS1 Mutations , 2010, Cell.

[14]  Ralph A. Nixon,et al.  Autophagy, amyloidogenesis and Alzheimer disease , 2007, Journal of Cell Science.

[15]  J. F. López-Téllez,et al.  Early neuropathology of somatostatin/NPY GABAergic cells in the hippocampus of a PS1×APP transgenic model of Alzheimer's disease , 2006, Neurobiology of Aging.

[16]  T. Bayer,et al.  Time sequence of maturation of dystrophic neurites associated with Aβ deposits in APP/PS1 transgenic mice , 2003, Experimental Neurology.

[17]  Thomas Arendt,et al.  Alzheimer's disease as a disorder of dynamic brain self-organization. , 2005, Progress in brain research.

[18]  D. Ruano,et al.  Inflammatory Response in the Hippocampus of PS1M146L/APP751SL Mouse Model of Alzheimer's Disease: Age-Dependent Switch in the Microglial Phenotype from Alternative to Classic , 2008, The Journal of Neuroscience.

[19]  Guojun Bu,et al.  Endocytosis Is Required for Synaptic Activity-Dependent Release of Amyloid-β In Vivo , 2008, Neuron.

[20]  M. Romero-Acebal,et al.  Calretinin interneurons are early targets of extracellular amyloid-beta pathology in PS1/AbetaPP Alzheimer mice hippocampus. , 2010, Journal of Alzheimer's disease : JAD.

[21]  A. Andreadis,et al.  Pathogenic Forms of Tau Inhibit Kinesin-Dependent Axonal Transport through a Mechanism Involving Activation of Axonal Phosphotransferases , 2011, The Journal of Neuroscience.

[22]  K. Zahs,et al.  Probing the Biology of Alzheimer's Disease in Mice , 2010, Neuron.

[23]  Carl W. Cotman,et al.  Identification and distribution of axonal dystrophic neurites in Alzheimer's disease , 1993, Brain Research.

[24]  J. Vickers,et al.  The morphological phenotype of β-amyloid plaques and associated neuritic changes in Alzheimer’s disease , 2001, Neuroscience.

[25]  D. Selkoe Alzheimer's Disease Is a Synaptic Failure , 2002, Science.

[26]  S. Ferreira,et al.  Amyloid-β Peptide Oligomers Disrupt Axonal Transport through an NMDA Receptor-Dependent Mechanism That Is Mediated by Glycogen Synthase Kinase 3β in Primary Cultured Hippocampal Neurons , 2010, The Journal of Neuroscience.

[27]  R. Castellani,et al.  Alzheimer disease. , 2010, Disease-a-month : DM.

[28]  Steven Mennerick,et al.  Synaptic Activity Regulates Interstitial Fluid Amyloid-β Levels In Vivo , 2005, Neuron.

[29]  A. Reith,et al.  Accumulation of autophagosomes after inhibition of hepatocytic protein degradation by vinblastine, leupeptin or a lysosomotropic amine. , 1982, Experimental cell research.

[30]  Kai Zhang,et al.  Tau Reduction Prevents Aβ-Induced Defects in Axonal Transport , 2010, Science.

[31]  S. Turner,et al.  Early-onset Amyloid Deposition and Cognitive Deficits in Transgenic Mice Expressing a Double Mutant Form of Amyloid Precursor Protein 695* , 2001, The Journal of Biological Chemistry.

[32]  J. Fiala Mechanisms of amyloid plaque pathogenesis , 2007, Acta Neuropathologica.

[33]  R. Shigemoto,et al.  Structural involvement of the glutamatergic presynaptic boutons in a transgenic mouse model expressing early onset amyloid pathology , 2003, Neuroscience Letters.

[34]  M. Ohno,et al.  Reversal of autophagy dysfunction in the TgCRND8 mouse model of Alzheimer's disease ameliorates amyloid pathologies and memory deficits. , 2011, Brain : a journal of neurology.

[35]  C. Cotman,et al.  Plasticity of hippocampal circuitry in Alzheimer's disease. , 1985, Science.

[36]  K. Bell,et al.  Altered synaptic function in Alzheimer's disease. , 2006, European journal of pharmacology.

[37]  E. Masliah,et al.  Immunoelectron microscopic study of synaptic pathology in Alzheimer's disease , 2004, Acta Neuropathologica.

[38]  C. Cotman,et al.  Senile plaques as aberrant sprout-stimulating structures , 1986, Experimental Neurology.

[39]  G. Gouras,et al.  Synapses, Synaptic Activity and Intraneuronal Aβ in Alzheimer's Disease , 2010, Front. Ag. Neurosci..

[40]  G. McCormack,et al.  Neurochemical Diversity of Dystrophic Neurites in the Early and Late Stages of Alzheimer's Disease , 1999, Experimental Neurology.

[41]  B. Hyman,et al.  Neuropathology of Alzheimer's disease. , 2008, Handbook of clinical neurology.

[42]  D. Ruano,et al.  Age-dependent Accumulation of Soluble Amyloid β (Aβ) Oligomers Reverses the Neuroprotective Effect of Soluble Amyloid Precursor Protein-α (sAPPα) by Modulating Phosphatidylinositol 3-Kinase (PI3K)/Akt-GSK-3β Pathway in Alzheimer Mouse Model* , 2011, The Journal of Biological Chemistry.

[43]  C. Duyckaerts,et al.  Alzheimer pathology disorganizes cortico-cortical circuitry: direct evidence from a transgenic animal model , 2004, Neurobiology of Disease.

[44]  S. M. Sumi,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1991, Neurology.

[45]  M. Romero-Acebal,et al.  Extracellular amyloid-beta and cytotoxic glial activation induce significant entorhinal neuron loss in young PS1(M146L)/APP(751SL) mice. , 2009, Journal of Alzheimer's disease : JAD.

[46]  D. Holtzman,et al.  Rapid appearance and local toxicity of amyloid-β plaques in a mouse model of Alzheimer’s disease , 2008, Nature.

[47]  F. Schmitt,et al.  Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment , 2007, Neurology.

[48]  W. Meier-Ruge,et al.  Neuronal Death versus Synaptic Pathology in Alzheimer's Disease , 2003, Annals of the New York Academy of Sciences.

[49]  B. Lamb,et al.  Autophagic vacuoles are enriched in amyloid precursor protein-secretase activities: implications for beta-amyloid peptide over-production and localization in Alzheimer's disease. , 2004, The international journal of biochemistry & cell biology.

[50]  D. Price,et al.  Loss of the Presynaptic Vesicle Protein Synaptophysin in Hippocampus Correlates with Cognitive Decline in Alzheimer Disease , 1997, Journal of neuropathology and experimental neurology.

[51]  C. Almeida,et al.  Intraneuronal Aβ accumulation and origin of plaques in Alzheimer's disease , 2005, Neurobiology of Aging.

[52]  E. Mandelkow,et al.  Aβ Oligomers Cause Localized Ca2+ Elevation, Missorting of Endogenous Tau into Dendrites, Tau Phosphorylation, and Destruction of Microtubules and Spines , 2010, The Journal of Neuroscience.

[53]  H. Vinters,et al.  AD synapses contain abundant Aβ monomer and multiple soluble oligomers, including a 56-kDa assembly , 2012, Neurobiology of Aging.

[54]  J. Vitorica,et al.  Involvement of mitochondria in the age-dependent decrease in calcium uptake of rat brain synaptosomes , 1986, Brain Research.

[55]  Ralph A. Nixon,et al.  Autophagy failure in Alzheimer's disease—locating the primary defect , 2011, Neurobiology of Disease.

[56]  Ralph A. Nixon,et al.  Autophagy Induction and Autophagosome Clearance in Neurons: Relationship to Autophagic Pathology in Alzheimer's Disease , 2008, The Journal of Neuroscience.

[57]  Y. Shitaka,et al.  Exclusive association and simultaneous appearance of congophilic plaques and AT8-positive dystrophic neurites in Tg2576 mice suggest a mechanism of senile plaque formation and progression of neuritic dystrophy in Alzheimer’s disease , 2004, Acta Neuropathologica.

[58]  F. Schmitt,et al.  Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment , 2006, Neurobiology of Aging.

[59]  E. Bigio,et al.  Alzheimer's disease-type neuronal tau hyperphosphorylation induced by Aβ oligomers , 2008, Neurobiology of Aging.

[60]  E. Masliah,et al.  Altered expression of synaptic proteins occurs early during progression of Alzheimer’s disease , 2001, Neurology.

[61]  H. Braak,et al.  Neuropathology of Alzheimer’s Disease , 2004 .

[62]  D. Ruano,et al.  Inter‐individual variability in the expression of the mutated form of hPS1M146L determined the production of Aβ peptides in the PS1xAPP transgenic mice , 2007, Journal of neuroscience research.

[63]  L. Thal,et al.  Aβ1–42 promotes cholinergic sprouting in patients with AD and Lewy body variant of AD , 2003, Neurology.

[64]  H. Cai,et al.  β‐Secretase‐1 elevation in transgenic mouse models of Alzheimer’s disease is associated with synaptic/axonal pathology and amyloidogenesis: implications for neuritic plaque development , 2009, The European journal of neuroscience.

[65]  A. Nógrádi,et al.  Severely dystrophic axons at amyloid plaques remain continuous and connected to viable cell bodies. , 2009, Brain : a journal of neurology.

[66]  R. D'Hooge,et al.  Lipids revert inert Aβ amyloid fibrils to neurotoxic protofibrils that affect learning in mice , 2007, The EMBO Journal.

[67]  J. Vickers,et al.  The morphological phenotype of beta-amyloid plaques and associated neuritic changes in Alzheimer's disease. , 2001, Neuroscience.

[68]  Brian J Cummings,et al.  Plaque biogenesis in brain aging and Alzheimer’s disease. II. Progressive transformation and developmental sequence of dystrophic neurites , 1998, Acta Neuropathologica.

[69]  E. Masliah,et al.  Axonopathy and Transport Deficits Early in the Pathogenesis of Alzheimer's Disease , 2005, Science.